(Q32062516)

English

No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study (English)

1 reference

Europe PubMed Central

6 July 2017

0 references

0 references

author name string

Mihara K

1

1 reference

Europe PubMed Central

6 July 2017

Kondo T

2

1 reference

Europe PubMed Central

6 July 2017

Suzuki A

3

1 reference

Europe PubMed Central

6 July 2017

Yasui N

4

1 reference

Europe PubMed Central

6 July 2017

Ono S

5

1 reference

Europe PubMed Central

6 July 2017

Otani K

6

1 reference

Europe PubMed Central

6 July 2017

Kaneko S

7

1 reference

Europe PubMed Central

6 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

6 July 2017

Psychiatry Research

1 reference

Europe PubMed Central

6 July 2017

101

1 reference

Europe PubMed Central

6 July 2017

33-38

1 reference

Europe PubMed Central

6 July 2017

1

1 reference

Europe PubMed Central

6 July 2017

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of zotepine and their relationship to serum concentrations of the drug and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot of plasma thioridazine and metabolites in chronically treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute dystonia during fixed-dose neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol blood levels and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolactin response to bromperidol treatment in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900247-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-1781(00)00247-X

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32062516&oldid=2042072028"